Biohaven Ltd. Stock Prediction
AI-powered sentiment analysis and prediction trends for BHVN, updated each market day.
BHVN AI Sentiment
AI predicts Biohaven Ltd. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Sector
Exchange
Market Cap
$2,097,998,118
Cap Tier
Employees
274
Headquarters
NEW HAVEN, CT
Listed Since
Sept. 23, 2022
Website
BHVN Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BHVN Volatility
Biohaven Ltd. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
